Literature DB >> 15694322

TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.

Zhaohui Shao1, Jeffrey L Browning, Xinhua Lee, Martin L Scott, Sveltlana Shulga-Morskaya, Norm Allaire, Greg Thill, Melissa Levesque, Dinah Sah, John M McCoy, Beth Murray, Vincent Jung, R Blake Pepinsky, Sha Mi.   

Abstract

Myelin-associated inhibitory factors (MAIFs) are inhibitors of CNS axonal regeneration following injury. The Nogo receptor complex, composed of the Nogo-66 receptor 1 (NgR1), neurotrophin p75 receptor (p75), and LINGO-1, represses axon regeneration upon binding to these myelin components. The limited expression of p75 to certain types of neurons and its temporal expression during development prompted speculation that other receptors are involved in the NgR1 complex. Here, we show that an orphan receptor in the TNF family called TAJ, broadly expressed in postnatal and adult neurons, binds to NgR1 and can replace p75 in the p75/NgR1/LINGO-1 complex to activate RhoA in the presence of myelin inhibitors. In vitro exogenously added TAJ reversed neurite outgrowth caused by MAIFs. Neurons from Taj-deficient mice were more resistant to the suppressive action of the myelin inhibitors. Given the limited expression of p75, the discovery of TAJ function is an important step for understanding the regulation of axonal regeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694322     DOI: 10.1016/j.neuron.2004.12.050

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  140 in total

1.  Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.

Authors:  Yong-Tang Wang; Xiu-Min Lu; Feng Zhu; Peng Huang; Ying Yu; Zai-Yun Long; Ya-Min Wu
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

2.  LINGO-1, a transmembrane signaling protein, inhibits oligodendrocyte differentiation and myelination through intercellular self-interactions.

Authors:  Scott Jepson; Bryan Vought; Christian H Gross; Lu Gan; Douglas Austen; J Daniel Frantz; Jacque Zwahlen; Derek Lowe; William Markland; Raul Krauss
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

Review 3.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

Review 4.  Targeting myelin to optimize plasticity of spared spinal axons.

Authors:  Angela L M Scott; Leanne M Ramer; Lesley J J Soril; Jacek M Kwiecien; Matt S Ramer
Journal:  Mol Neurobiol       Date:  2006-04       Impact factor: 5.590

Review 5.  Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury?

Authors:  Noam Y Harel; Stephen M Strittmatter
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

Review 6.  Glial inhibition of CNS axon regeneration.

Authors:  Glenn Yiu; Zhigang He
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

Review 7.  Extracellular regulators of axonal growth in the adult central nervous system.

Authors:  Betty P Liu; William B J Cafferty; Stephane O Budel; Stephen M Strittmatter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

Review 8.  Recapitulate development to promote axonal regeneration: good or bad approach?

Authors:  Marie T Filbin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

9.  LINGO-1 protein interacts with the p75 neurotrophin receptor in intracellular membrane compartments.

Authors:  James S Meabon; Rian De Laat; Katsuaki Ieguchi; Jesse C Wiley; Mark P Hudson; Mark Bothwell
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

10.  Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.

Authors:  Benxiu Ji; Mingwei Li; Stephane Budel; R Blake Pepinsky; Lee Walus; Thomas M Engber; Stephen M Strittmatter; Jane K Relton
Journal:  Eur J Neurosci       Date:  2005-08       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.